FINWIRES · TerminalLIVE
FINWIRES

Eureka Lithium Announces Name Change to Eureka Metals Corp.

By

Eureka Lithium (ERKA.CN) on Monday said it plans to change its name to Eureka Metals.

The Canadian Securities Exchange will publish a bulletin announcing the effective date of the change and it is expected the shares will begin trading under its new name on or about May 14.

"The name change reflects the company's strategic evolution beyond lithium exploration and aligns with its recently announced acquisition of Stairway Mining," said the company.

The shares will continue to trade under its existing symbols on the Canadian Securities Exchange (CSE), OTCQB, and Frankfurt Stock Exchange (FSE), said the company and added that the CUSIP and ISIN will change to 298601105 and CA2986011054 respectively.

"The transition to Eureka Metals Corp. reflects the evolution of the company and the broader commodity exposure established through the acquisition of Stairway Mining," said chief executive Danny Matthews. "With the addition of the Tyee Titanium Project and the Cabin Lake Polymetallic Project, combined with a strong treasury following our recent financing, we believe the company is well-positioned to advance multiple exploration initiatives across a diversified portfolio of metals projects in Canada."

The company's shares last traded May 8, closing at $0.43 on the Canadian Securities Exchange.

Related Articles

Mining & Metals

Crescita Therapeutics' Q1 Loss Widens Even as Revenue Advances

Crescita Therapeutics (CTX.TO) on Monday said its first-quarter loss widened even as revenue advanced.The company, which being acquired by ClinActiv Holdings, said its first-quarter loss widened to $1.2 million, or $0.06 per share, from a loss of $0.7 million, or $0.05 per share, in the prior-year period.Revenue rose to $5.64 million from $3.54 million a year earlier. The rise of $2.1 million was primarily driven by higher manufacturing segment revenue of $1.6 million, mainly due to the fulfillment of large orders during the quarter. Skincare sales also increased by $592,000, mainly reflecting incremental revenue from Bacti Control, acquired last August."During the first quarter, we continued to execute against our operational priorities. Our results reflect the year-over-year revenue and gross profit growth, driven by higher production volumes in our Manufacturing segment as well as the incremental revenue from recently acquired skincare assets," said chief executive Serge Verreault.Crescita Therapeutics was last seen unchanged at $0.76, on the Toronto Stock Exchange.

$CTX.TO
Mining & Metals

Thiogenesis Therapeutics to Raise $8 Million Via a Non-Brokered Private Placement

Thiogenesis Therapeutics (TTI.V) on Monday said it will raise up to $8 million in a non-brokered private placement of shares.The company will place up to 16-million shares priced at $0.50 apiece.The company expects to close the offering by the end of May subject to receipt of all necessary regulatory approvals.Proceeds will be used to support the clinical development of TTI-0102, including an investigator-initiated study in cystinosis and a Phase 2 clinical study in Leigh syndrome, together with formulation and manufacturing activities, regulatory engagement, and general working capital and corporate needs.The company's shares last traded May 8, closing at $0.56 on the TSX Venture Exchange.

$TTI.V
Mining & Metals

TSX up 102 Points at Midday With Miners, Energy, The Best Performers

The Toronto Stock Exchange is up 102 points at midday with most sectors higher.Miners and energy are the best performers, up 2.8% and 1.3%, respectively.Info tech and Industrials are the worst performers, down 2.5% and 1.3%, respectively.Oil prices rose early on Monday after the United States rejected Iran's response to its peace proposal, calling it unacceptable, continuing the war that has produced the largest-ever energy supply shock.Gold traded lower early Monday as the dollar and yields rose after the United States rejected Iran's response to its peace plan offered last week, calling the country's response unacceptable.The Bank of Canada is seen increasing its policy rate in March 2027, according to findings in its own first quarter Market Participants Survey (MPS) released Monday. The MPS showed a median of 28 financial participants expect the policy rate to rise by 25bps to 2.50% in March 2027. The Q4 2025 MPS had predicted a 25bps rate hike in Q2 2027. Among other findings, a median of market participants forecast the consumer price index to be 2.6% at the end of the year and 2.1% at the end of 2027. The Q4 2025 MPS had projected CPI at 2.1% at the end of this year, as well as 12 months later.The Q1 MPS also showed the median response saw gross domestic product growth at 1.6% this year and at 1.9% in 2027. Both are unchanged from the previous survey. The survey was conducted from March 25 to April 1.

$^GSPTSE$.GSPTSE